Despite the central role of TREM-2 in Alzheimer’s disease, metabolic syndrome, cancer, and other diverse pathologies causing it to attract considerable recent attention [36], its role in RA is not well understood. This evidence concerns the gene TREM2 and early-onset autosomal dominant Alzheimer disease.